ZA953877B - Novel process - Google Patents

Novel process

Info

Publication number: ZA953877B
Authority: ZA; South Africa
Prior art keywords: group; formula; image; compound; pharmaceutically acceptable
Prior art date: 1994-05-14

Application number

ZA953877A

Other languages

English (en)

Inventor

Steven Mark Bromidge

Martyn Voyle

Erolali Faruk

Mark Jason Hughes

John Kitteringham

Gary Thomas Borrett

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-14

Filing date

1995-05-12

Publication date

1996-03-07

1995-05-12 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1996-03-07 Publication of ZA953877B publication Critical patent/ZA953877B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Catalysts (AREA)
Saccharide Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA953877A 1994-05-14 1995-05-12 Novel process ZA953877B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9409705A GB9409705D0 (en)	1994-05-14	1994-05-14	Novel compounds

Publications (1)

Publication Number	Publication Date
ZA953877B true ZA953877B (en)	1996-03-07

Family

ID=10755162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA953877A ZA953877B (en)	1994-05-14	1995-05-12	Novel process

Country Status (22)

Country	Link
US (2)	US5808075A (xx)
EP (1)	EP0759921B1 (xx)
JP (1)	JPH10500119A (xx)
KR (1)	KR100340396B1 (xx)
CN (3)	CN1048013C (xx)
AT (1)	ATE244718T1 (xx)
AU (1)	AU695838B2 (xx)
BR (1)	BR9507659A (xx)
CA (1)	CA2190278A1 (xx)
CZ (1)	CZ334796A3 (xx)
DE (1)	DE69531242T2 (xx)
DK (1)	DK0759921T3 (xx)
ES (1)	ES2202364T3 (xx)
GB (1)	GB9409705D0 (xx)
HK (1)	HK1012367A1 (xx)
HU (1)	HU216629B (xx)
NO (1)	NO964818L (xx)
NZ (1)	NZ287038A (xx)
PL (1)	PL178720B1 (xx)
PT (1)	PT759921E (xx)
WO (1)	WO1995031456A1 (xx)
ZA (1)	ZA953877B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9421472D0 (en) *	1994-10-25	1994-12-07	Smithkline Beecham Plc	Novel methods
AU751607B2 (en) *	1995-07-29	2002-08-22	Smithkline Beecham Plc	Method of treatment of dementia
GB9615628D0 (en) *	1996-07-25	1996-09-04	Smithkline Beecham Plc	Formulation
EP1009403A4 (en) *	1997-04-11	2002-08-28	Lilly Co Eli	METHOD FOR TREATING SCHIZOPHRENIA
WO2006006071A1 (en) *	2004-07-07	2006-01-19	Pfizer Products Inc.	Resolution of an aryl-fused azapolycyclic compound
GB0428170D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Mono and Combination Therapy
AU2006282896A1 (en) *	2005-08-26	2007-03-01	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en)	2005-10-21	2008-07-09	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
CA2625210A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US7678808B2 (en)	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
EP2382975A3 (en)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenesis by modulating angiotensin
JP2010502722A (ja)	2006-09-08	2010-01-28	ブレインセルス，インコーポレイティド	４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3904632A (en) *	1972-05-08	1975-09-09	Hoffmann La Roche	(')-di-o-isopropylidene-2-keto-l-gulonates
FR2183565B1 (xx) *	1972-05-10	1975-12-26	Cerm Cent Europ Rech Mauvernay
CA1014958A (en) *	1973-10-05	1977-08-02	Jacques Moleyre	.alpha.-QUINUCLIDYLMETHYL PHENYL KETONES
WO1984000957A1 (en) *	1982-09-07	1984-03-15	Yoshitomi Pharmaceutical	4-amino-tetrahydro-2-naphthoic acid derivatives
DE69034146T2 (de) *	1989-04-13	2005-07-14	Beecham Group P.L.C., Brentford	Chemische Verbindungen
DK198590D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) *	1990-08-21	1995-05-23	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
MX9300875A (es) *	1992-02-20	1993-08-31	Smithkline Beecham Plc	Procedimiento para la preparacion de compuestos azabiciclicos.

1994
- 1994-05-14 GB GB9409705A patent/GB9409705D0/en active Pending
1995
- 1995-05-09 HU HU9603145A patent/HU216629B/hu not_active IP Right Cessation
- 1995-05-09 ES ES95920011T patent/ES2202364T3/es not_active Expired - Lifetime
- 1995-05-09 BR BR9507659A patent/BR9507659A/pt not_active Application Discontinuation
- 1995-05-09 US US08/737,427 patent/US5808075A/en not_active Expired - Fee Related
- 1995-05-09 DE DE69531242T patent/DE69531242T2/de not_active Expired - Fee Related
- 1995-05-09 NZ NZ287038A patent/NZ287038A/en unknown
- 1995-05-09 AU AU25628/95A patent/AU695838B2/en not_active Ceased
- 1995-05-09 PL PL95317210A patent/PL178720B1/pl not_active IP Right Cessation
- 1995-05-09 CA CA002190278A patent/CA2190278A1/en not_active Abandoned
- 1995-05-09 AT AT95920011T patent/ATE244718T1/de not_active IP Right Cessation
- 1995-05-09 EP EP95920011A patent/EP0759921B1/en not_active Expired - Lifetime
- 1995-05-09 CZ CZ963347A patent/CZ334796A3/cs unknown
- 1995-05-09 PT PT95920011T patent/PT759921E/pt unknown
- 1995-05-09 CN CN95193952A patent/CN1048013C/zh not_active Expired - Fee Related
- 1995-05-09 WO PCT/EP1995/001757 patent/WO1995031456A1/en not_active Application Discontinuation
- 1995-05-09 KR KR1019960706442A patent/KR100340396B1/ko not_active IP Right Cessation
- 1995-05-09 JP JP7529334A patent/JPH10500119A/ja not_active Ceased
- 1995-05-09 DK DK95920011T patent/DK0759921T3/da active
- 1995-05-12 US US08/439,616 patent/US5773619A/en not_active Expired - Fee Related
- 1995-05-12 ZA ZA953877A patent/ZA953877B/xx unknown
1996
- 1996-11-13 NO NO964818A patent/NO964818L/no unknown
1998
- 1998-12-15 HK HK98113521A patent/HK1012367A1/xx not_active IP Right Cessation
1999
- 1999-03-13 CN CN99103926A patent/CN1104431C/zh not_active Expired - Fee Related
- 1999-03-13 CN CN99103925A patent/CN1108302C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HK1012367A1 (en)	1999-07-30
CN1270170A (zh)	2000-10-18
EP0759921B1 (en)	2003-07-09
ES2202364T3 (es)	2004-04-01
CN1048013C (zh)	2000-01-05
US5773619A (en)	1998-06-30
HU216629B (hu)	1999-07-28
AU2562895A (en)	1995-12-05
BR9507659A (pt)	1997-10-07
AU695838B2 (en)	1998-08-20
PL178720B1 (pl)	2000-06-30
CZ334796A3 (en)	1997-07-16
KR100340396B1 (ko)	2002-10-25
DE69531242D1 (de)	2003-08-14
DE69531242T2 (de)	2004-05-27
CN1151743A (zh)	1997-06-11
CN1104431C (zh)	2003-04-02
NO964818D0 (no)	1996-11-13
PT759921E (pt)	2003-11-28
EP0759921A1 (en)	1997-03-05
NO964818L (no)	1997-01-13
HU9603145D0 (en)	1997-01-28
GB9409705D0 (en)	1994-07-06
PL317210A1 (en)	1997-03-17
ATE244718T1 (de)	2003-07-15
NZ287038A (en)	1997-11-24
CN1108302C (zh)	2003-05-14
HUT75309A (en)	1997-05-28
KR970703342A (ko)	1997-07-03
US5808075A (en)	1998-09-15
WO1995031456A1 (en)	1995-11-23
CN1232825A (zh)	1999-10-27
JPH10500119A (ja)	1998-01-06
CA2190278A1 (en)	1995-11-23
DK0759921T3 (da)	2003-11-03

Similar Documents

Publication	Publication Date	Title
ZA953877B (en)	1996-03-07	Novel process
US4302465B1 (xx)	1984-01-24
ZA944884B (en)	1995-02-20	Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent
HU9702482D0 (en)	1998-03-02	New intermediates for producing gaba and l-glutaminic acid analogues
GR69233B (xx)	1982-05-10
ES8503667A1 (es)	1985-03-16	Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
DE3372362D1 (en)	1987-08-13	Polyprenylcarboxylic acid amides and process for preparing the same
CA2131019A1 (en)	1993-08-21	Nitrosation process
IE781926L (en)	1979-04-03	Peptides analgesics
ZA816259B (en)	1983-04-27	2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
IE830278L (en)	1983-08-12	Corynanthein derivatives, anti-hypertensives
HUT50845A (en)	1990-03-28	Process for producing 14,17beta-ethano-14beta-estratrienes and pharmaceutical compositions comprising same
ES8401761A1 (es)	1984-01-01	Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
CA2208520A1 (en)	1996-07-04	Diclavulanate salt with a diamino ether and process of preparation
MX9605632A (es)	1998-02-28	Procedimiento para la preparacion de derivados azabiciclicos.
DE3564426D1 (en)	1988-09-22	Polyprenyl compound, process of producing it and pharmaceutical use
ES479712A1 (es)	1980-08-16	Procedimiento para la preparacion de n-bencilaminoacidos quecontienen azufre.
ATE20742T1 (de)	1986-08-15	Verfahren zur herstellung von pyrazin-derivaten.
ES2007784A6 (es)	1989-07-01	Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
IL113757A (en)	1997-03-18	Preparation of clavulanic acid
ES481416A1 (es)	1980-08-16	Un procedimiento para la preparacion de un derivado monoami-da de acido tereftalico.
ES8704175A1 (es)	1987-03-16	Un procedimiento para la preparacion de derivados de benzopirano (2,3-d) triazol.
ATE49967T1 (de)	1990-02-15	Verfahren zur herstellung von n-methyl-derivaten von methylester von dihydrolyserginesaeure oder von methylester von methoxylumilyserginesaeure.